Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Genes|September 23, 2022
The Complete Mitochondrial Genome of Spirobolus bungii (Diplopoda, Spirobolidae): The First Sequence for the Genus SpirobolusHanmei Xu, Yu Fang, Guohua Cao, et al.
Signal Transduction and Targeted Therapy|July 6, 2022
Trends in insulin resistance: insights into mechanisms and therapeutic strategyMengwei Li, Xiaowei Chi, Ying Wang, et al.
Genomics|May 27, 2020
Characterization of the complete mitochondrial genome of Drawida gisti (Metagynophora, Moniligastridae) and comparison with other Metagynophora speciesHongyi Liu, Nan Xu, Qingzheng Zhang, et al.
Acta Pharmaceutica Sinica. B|September 30, 2021
Integrins as attractive targets for cancer therapeuticsMeng Li, Ying Wang, Mengwei Li, et al.
Cancer Immunology, Immunotherapy : CII|July 7, 2023
CD24 is a novel target of chimeric antigen receptor T cells for the treatment of triple negative breast cancerPeiwei Yang, Fan Yu, Zheng Yao, et al.
International Journal of Medical Sciences|July 26, 2019
Anti-Tumor Activity and Pharmacokinetics of AP25-Fc Fusion ProteinDening Pei, Jialiang Hu, Chunming Rao, et al.
Molecular Medicine Reports|June 12, 2015
Anti-tumor peptide AP25 decreases cyclin D1 expression and inhibits MGC-803 proliferation via phospho-extracellular signal-regulated kinase-, Src-, c-Jun N-terminal kinase- and phosphoinositide 3-kinase-associated pathwaysJialiang Hu, Tao Cheng, Lijun Zhang, et al.
Cancers|September 13, 2025
A Novel Nuclear-Localized Micropeptide, MP60, Promotes Hepatocellular Carcinoma Progression via the Epithelial-Mesenchymal TransitionChencheng Li, Xiu Hong, Sarra Setrerrahmane, et al.
Molecular Medicine Reports|July 3, 2026
[Retracted] Anti‑tumor peptide AP25 decreases cyclin D1 expression and inhibits MGC‑803 proliferation via phospho-extracellular signal‑regulated kinase‑, Src‑, c‑Jun N‑terminal kinase‑ and phosphoinositide 3--kinase‑associated pathwaysJialiang Hu, Tao Cheng, Lijun Zhang, et al.
International Journal of Molecular Sciences|February 1, 2019
Design and Synthesis of A PD-1 Binding Peptide and Evaluation of Its Anti-Tumor ActivityAbdul Baset Abbas, Bingjing Lin, Chen Liu, et al.
Pageof 11